Summary
The effect of advanced age on drug disposition and response is the subject of an increasing number of research studies. Cigarette smoking and other environmental factors have been shown to influence the metabolism of some drugs. Studies of the effect of age on the pharmacokinetics of antipyrine, indocyanine green and propranolol indicate that the association of increased drug metabolism and smoking occurs predominantly in the young and that apparent liver blood flow declines with age regardless of smoking habits. This age related effect of smoking on drug metabolism may reflect a reduced capacity for hepatic enzyme induction in the elderly. The relative importance of age related alterations in the intrinsic drug metabolising ability of the liver and in liver blood flow depend on the pharmacokinetic characteristics of the drug being investigated.
Similar content being viewed by others
References
Adelman, R.C.: Age-dependent effects of enzyme induction — A biochemical expression of aging. Experimental Gerontology 6: 75–87 (1971).
Bender, A.D.: The effect of increasing age on the distribution of peripheral blood flow in man. Journal of the American Geriatric Society 13: 192–198 (1965).
Birnbaum, L.S. and Baird, M.B.: Induction of hepatic mixed function oxidases in senescent rodents. Experimental Gerontology 13: 229–303 (1978).
Blaschke, T.F.: Protein binding and kinetics of drugs in liver diseases. Clinical Pharmacokinetics 2: 32–44 (1977).
Brandfonbrener, M.; Landowne, M. and Shock, N.: Changes in cardiac output with age. Circulation 12: 557–566 (1955).
Castleden, C.M. and George, C.F.: The effect of ageing on the hepatic clearance of propranolol. British Journal of Clinical Pharmacology 7: 49–54 (1979).
Castleden, C.M.; Kayne, C.M. and Parsons, R.L.: The effect of age on plasma levels of propranolol and practolol in man. British Journal of Clinical Pharmacology 2: 303–306 (1975).
Conney, A.H.; Pantuck, E.J.; Hsiao, K.-C; Kuntzman, R.; Alvares, A.P. and Kappas, A.: Regulation of drug metabolism in man by environmental chemicals and diet. Federation Proceedings 36: 1647–1652 (1977).
Crooks, J.; Os’Malley, K. and Stevenson, I.H.: Pharmacokinetics in the elderly. Clinical Pharmacokinetics 1: 280–296 (1976).
Hart, P.; Farrell, G.C.; Cooksley, W.G.E. and Powell, L.W.: Enhanced drug metabolism in cigarette smokers. British Medical Journal 3: 147–149 (1976).
Jick, H.: Smoking and clinical drug effects. Medical Clinics of North America 58: 1143–1149 (1974).
Jusko, W.J.: Role of tobacco smoking in pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics 6: 7–39 (1978).
Kapitulnik, J.; Poppers, P.J. and Conney, A.J.: Comparative metabolism of benzo(a)pyrene and drugs in human liver. Clinical Pharmacology and Therapeutics 21: 166–176 (1977).
Kato, R. and Takanaka, A.: Metabolism of drugs in old rats. I. Activities of NADPH-linked electron transport and drug metabolizing enzyme systems in liver microsomes of old rats. Japanese Journal of Pharmacology 18: 381–388 (1968a).
Kato, R. and Takanaka, A.: Effect of phenobarbital on electron transport system, oxidation and reduction of drugs in liver microsomes of rats of different ages. Journal of Biochemistry 63: 406–408 (1968b).
Lewis, G.P.; Jusko, W.J.; Coughlin, L.L. and Hartz, S.: Cadmium accumulation in man. Influence of smoking, occupation, alcoholic habit and disease. Journal of Chronic Diseases 25: 717–726 (1972).
Liddell, D.E.; Williams, F.M. and Briant, R.H.: Phenazone (antipyrine) metabolism and distribution in young and elderly adults. Clinical and Experimental Pharmacology and Physiology 2: 481–487 (1975).
Nebert, D.W.; Winker, J. and Gelboin, H.V.: Aryl hydrocarbon hydroxylase activity in human placenta from cigarette smoking and nonsmoking women. Cancer Research 29: 1763–1769 (1969).
Pelkonen, O.; Metabolism of benzo(a)pyrene in human adults and fetal tissues; in Freudenthal and Jones (Eds), Carcinogenesis, Vol. 1: Polynuclear Aromatic Hydrocarbons: Chemistry, Metabolism, and Carcinogenesis, pp. 9–12 (Raven Press, New York 1976).
Os’Malley, K.; Crooks, J.; Duke, E. and Stevenson, I.H.: Effect of age and sex on human drug metabolism. British Medical Journal 3: 607–609 (1971).
Rasmussen, S.N.; Hansen, J.M.; Kampmann, J.P.; Skovstad, L. and Bach, B.: Drug metabolism in relation to liver volume and age (Abst). Scandinavian Journal of Gastroenterology 11: 86 (1976).
Richey, D.P. and Bender, D.: Pharmacokinetic consequences of aging. Annual Review of Pharmacology and Toxicology 17: 49–65 (1977).
Rowe, J.W.: Clinical research on aging: Strategies and directions. New England Journal of Medicine 297: 1332–1336 (1977).
Swift, C.G.; Homeida, M.; Halliwell, M. and Roberts, C.J.C.: Antipyrine disposition and liver size in the elderly. European Journal of Clinical Pharmacology 14: 149–152 (1978).
Triggs, E.J. and Nation, R.L.: Pharmacokinetics in the aged: A review. Journal of Pharmacokinetics and Biopharmaceutics 3: 387–418 (1975).
U.S. Department of Health, Education and Welfare: Smoking and Health-, A Report of the Surgeon General. DHEW Publication No. (PHS) 79-50066. Washington D.C. (1979), pp.12-1–12-91.
Vestal, R.E.: Aging and pharmacokinetics: Impact of altered physiology in the elderly; in Cherkin, Finch, Karash, Makinodan, Scott and Strehler (Eds) Physiology and Cell Biology of Aging (Aging, Volume 8) pp. 185–201, (Raven Press, New York 1979).
Vestal, R.E.: Drug use in the elderly: A review of problems and special considerations. Drugs 16: 358–382 (1978).
Vestal, R.E.; Norris, A.H.; Tobin, J.D.; Cohen, B.H.; Shock, N.W. and Andres, R.: Antipyrine metabolism in man: Influence of age, alcohol, caffeine, and smoking. Clinical Pharmacology and Therapeutics 18: 425–432 (1975).
Vestal, R.E.; Wood, A.J.J.; Branch, R.A.; Shand, D.G. and Wilkinson, G.R.: Effects of age and cigarette smoking on the disposition of propranolol in man. Clinical Pharmacology and Therapeutics 26: 8–15 (1979).
Walle, T.; Conradi, E.C.; Walle, U.K.: Fagan, T.C. and Gaffney, T.C.: The predictable relationship between plasma levels and dose during chronic propranolol therapy. Clinical Pharmacology and Therapeutics 24: 668–677 (1978).
Welch, R.M.; Cavallito, J. and Gillespie, D.D.: Effects of analgesics and exposure to cigarette smoke on the metabolism of acetophenetidin by rat tissues. Drug Metabolism and Disposition 1: 211–215 (1973).
Welch, R.M.; Harrison, Y.E.; Conney, A.H.; Poppers, P.J. and Finster, M.: Cigarette smoking: Stimulatory effect on metabolism of 3,4-benzpyrene by enzymes in human placenta. Science 160: 541–542 (1968).
Welch, R.M.; Hughes, C.R. and De Angelis, R.L.: Effect of 3-methylcholantherene pretreatment on the bioavailability of phenacetin in the rat. Drug Metabolism and Disposition 4: 402–406 (1976).
Wilkinson, G.R. and Shand, D.G.: A physiological approach to hepatic drug clearance. Clinical Pharmacology and Therapeutics 18: 377–390 (1975).
Wilson, J.T.; Van Boxtel, C.J.; Alvan, G. and Sjoqvist, F.: Failure of vitamin C to affect the pharmacokinetic profile of anti-pyrine in man. Journal of Clinical Pharmacology 16: 265–270 (1976).
Wood, A.J.J.; Vestal, R.E.; Wilkinson, G.R.; Branch, R.A. and Shand, D.C.: Effects of aging and cigarette smoking on anti-pyrine and indocyanine green elimination. Clinical Pharmacology and Therapeutics 26: 16–20 (1979).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vestal, R.E., Wood, A.J.J. Influence of Age and Smoking on Drug Kinetics in Man Studies Using Model Compounds. Clin Pharmacokinet 5, 309–319 (1980). https://doi.org/10.2165/00003088-198005040-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-198005040-00001